Scarica l'app Stockscreener
18.04
11.56%
1.86
Dopo l'orario di chiusura:
17.00
-1.04
-5.76%
Precedente Chiudi:
$16.18
Aprire:
$16.13
Volume 24 ore:
774.80K
Relative Volume:
1.30
Capitalizzazione di mercato:
$988.27M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+22.12%
1M Prestazione:
+5.80%
6M Prestazione:
+23.71%
1 anno Prestazione:
+1.58%
Intervallo 1D:
$15.83
$18.16
Intervallo di 1 settimana:
$14.62
$18.16
Portata 52W:
$7.80
$22.68
Bicara Therapeutics Inc Stock (BCAX) Company Profile
Nome
Bicara Therapeutics Inc
Settore
Industria
Telefono
617-468-4219
Indirizzo
116 HUNTINGTON AVENUE SUITE 703, BOSTON
Confronta BCAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BCAX
Bicara Therapeutics Inc
|
18.04 | 886.37M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Bicara Therapeutics Inc Stock (BCAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-05-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2025-04-17 | Iniziato | Wells Fargo | Underweight |
| 2025-02-06 | Iniziato | Wedbush | Outperform |
| 2024-12-06 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-05 | Iniziato | Rodman & Renshaw | Buy |
| 2024-10-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-10-08 | Iniziato | Morgan Stanley | Overweight |
| 2024-10-08 | Iniziato | Stifel | Buy |
| 2024-10-08 | Iniziato | TD Cowen | Buy |
Mostra tutto
Bicara Therapeutics Inc Borsa (BCAX) Ultime notizie
How Bicara Therapeutics Inc. stock reacts to job market data2025 Price Targets & Safe Entry Momentum Stock Tips - newser.com
Is Bicara Therapeutics Inc. stock safe for conservative investors - newser.com
Why Bicara Therapeutics Inc. stock appeals to analysts2025 Breakouts & Breakdowns & Reliable Momentum Entry Alerts - newser.com
What risks investors should watch in Bicara Therapeutics Inc. stock2025 EndofYear Setup & Consistent Income Trade Recommendations - newser.com
Should I hold or sell Bicara Therapeutics Inc. stock in 2025Insider Buying & Reliable Momentum Entry Alerts - newser.com
What dividend safety score for Bicara Therapeutics Inc. stockWall Street Watch & Long-Term Capital Growth Strategies - newser.com
Bicara Therapeutics Inc. (NASDAQ:BCAX) Receives $29.67 Average Price Target from Analysts - Defense World
Analyzing Bicara Therapeutics Inc. with risk reward ratio chartsTrade Volume Report & High Conviction Buy Zone Picks - newser.com
Taking the lead: Bicara Therapeutics Inc (BCAX) - Setenews
How currency fluctuations impact Bicara Therapeutics Inc. stock2025 Market WrapUp & Accurate Buy Signal Alerts - newser.com
How to manage a losing position in Bicara Therapeutics Inc.Market Activity Summary & Fast Gain Swing Alerts - newser.com
How institutional buying supports Bicara Therapeutics Inc. stock2025 Geopolitical Influence & Capital Protection Trading Alerts - newser.com
Is Bicara Therapeutics Inc. stock resilient to inflationQuarterly Earnings Summary & Daily Technical Forecast Reports - newser.com
What institutional flow reveals about Bicara Therapeutics Inc.Weekly Market Report & Weekly High Conviction Trade Ideas - newser.com
Will a bounce in Bicara Therapeutics Inc. offer an exitTreasury Yields & AI Powered Market Entry Strategies - newser.com
Bicara Therapeutics (NASDAQ:BCAX) Earns “Outperform” Rating from Wedbush - Defense World
Wedbush Has Bearish Estimate for BCAX FY2025 Earnings - Defense World
How Bicara Therapeutics Inc. stock benefits from global expansion2025 Earnings Impact & Community Verified Swing Trade Signals - newser.com
Real time alert setup for Bicara Therapeutics Inc. performance2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com
Wells Fargo Maintains Bicara Therapeutics (BCAX) Equal-Weight Recommendation - Nasdaq
An analyst sees good growth prospects for Bicara Therapeutics Inc (BCAX) - Setenews
HC Wainwright & Co. Initiates Coverage of Bicara Therapeutics (BCAX) with Buy Recommendation - MSN
Bicara Therapeutics Inc Azioni (BCAX) Dati Finanziari
Non sono disponibili dati finanziari per Bicara Therapeutics Inc (BCAX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Bicara Therapeutics Inc Azioni (BCAX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan | President and COO |
Oct 15 '25 |
Sale |
18.16 |
12,500 |
226,942 |
198,141 |
1.33%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):